ORAL-CONTRACEPTIVES - RELATION TO MAMMARY-CANCER, BENIGN BREAST LESIONS, AND CERVICAL-CANCER

被引：19

作者：

DRILL, VA

机构：

[1] GD SEARLE & CO, RES DIV, CHICAGO, IL 60600 USA

[2] UNIV ILLINOIS, COLL MED, MED CTR, DEPT PHARMACOL, CHICAGO, IL 60680 USA

来源：

关键词：

D O I：

10.1146/annurev.pa.15.040175.002055

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：367 / 385

页数：19

共 161 条

[1]

ANDELMAN MB, 1968, INT J FERTIL, V13, P405

[2]

[Anonymous], 1973, Lancet, V1, P1399

[3]

ARTHES FG, 1971, CANCER, V28, P1391, DOI 10.1002/1097-0142(197112)28:6<1391::AID-CNCR2820280609>3.0.CO

[4]

2-S

[5]

Attwood M E, 1966, J Obstet Gynaecol Br Commonw, V73, P662

[6]

AYRE JE, 1966, OBSTET GYNECOL, V28, P90

[7]

AYRE JE, 1969, OBSTET GYNECOL, V34, P545

[8]

BAKER W, 1960, BIOLOGICAL ACTIVITIE, P371

[9]

BARRON BA, 1968, J NATL CANCER I, V41, P1343

[10]

Beatson, 1896, LANCET, V15, P153, DOI DOI 10.1016/S0140-6736(01)72307-0